Tocolytic Agents: all 717 studies that test it
Page 8 of 8. Open to participants first (116), then studies with results posted, then the rest; newest registration first within each.
- Magnesium Sulfate to Prevent Brain Injury in Premature InfantsStatus unknownNCT00065949Phase 3
- Treatment of Multiple Sclerosis With Copaxone and AlbuterolCompletedNCT00039988Not applicable
- Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)CompletedNCT00027391Not applicable
- Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)CompletedNCT00014989Phase 3
- Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)CompletedNCT00009646Phase 3
- Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver DiseaseCompletedNCT00007033Not applicable
- A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic FibrosisSuspendedNCT00005110Not applicable
- Magnesium Sulfate For Brain InjuryCompletedNCT00004730Phase 3
- Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular DystrophyCompletedNCT00004685Not applicable
- Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe PreeclampsiaCompletedNCT00004399Not applicable
- Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 DiabetesCompletedNCT00004266Phase 3
- Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerTerminatedNCT00002796Phase 1/2
- Indomethacin Plus Biological Therapy in Treating Patients With Advanced MelanomaCompletedNCT00002535Phase 2
- Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot StudyCompletedNCT00002146Phase 4
- Raynaud's Treatment Study (RTS)CompletedNCT00000530Phase 3
- Management of Patent Ductus in Premature InfantsCompletedNCT00000494Phase 3
- Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic TargetsCompletedNCT00000102Phase 1/2